Clinical Trials Directory

Trials / Completed

CompletedNCT03795038

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI

Comparison of the Plasma Lipoprotein Apheresis Systems DIAMED and MONET vs. the Whole Blood Apheresis System DALI: Cross-over Study in Patients With Cardiovascular Disease and Severe Dyslipidemia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Fresenius Medical Care Deutschland GmbH · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical Investigation will be performed to compare the safety and effectiveness of the CE certified and established lipoprotein apheresis systems MONET vs. DALI and DIAMED vs. DALI for optimizing the individual therapy of patients with severe dyslipidemia using established and novel efficacy parameters.

Detailed description

Comparison of the safety and effectiveness of the CE certified and established lipoprotein apheresis systems MONET vs. DALI and DIAMED vs. DALI for optimizing the individual therapy of patients with severe dyslipidemia using established and novel efficacy parameters. The primary objective is to compare the whole blood lipoprotein apheresis system DALI with the plasma lipoprotein apheresis systems MONET and DIAMED with regard to their efficacies in removing total cholesterol, low density lipoprotein cholesterol (LDL-C), triglycerides and lipoprotein (a) (Lp(a)). The secondary objective is to compare the whole blood lipoprotein apheresis system DALI with the plasma lipoprotein apheresis system MONET and DIAMED with regard to their efficacies in removing other novel efficacy parameters.

Conditions

Interventions

TypeNameDescription
DEVICELipoprotein Apheresis MONET and DALIThree apheresis treatments assigned to one type of apheresis system of MONETand DALI
DEVICELipoprotein Apheresis DIAMED and DALIThree apheresis treatments assigned to one type of apheresis system of DIAMOND and DALI

Timeline

Start date
2018-12-28
Primary completion
2021-05-25
Completion
2021-05-25
First posted
2019-01-07
Last updated
2022-07-28

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT03795038. Inclusion in this directory is not an endorsement.